Aspiriant LLC’s iShares Russell 2000 ETF IWM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.5M Sell
54,901
-829
-1% -$233K 0.41% 36
2026
Q1
$13.8M Buy
55,730
+1,302
+2% +$336K 0.39% 37
2025
Q4
$13.4M Buy
54,428
+8,186
+18% +$2.01M 0.38% 37
2025
Q3
$11.2M Sell
46,242
-216
-0.5% -$49.6K 0.34% 38
2025
Q2
$10M Sell
46,458
-404
-0.9% -$81.3K 0.32% 39
2025
Q1
$9.35M Buy
46,862
+20
+0% +$4.34K 0.32% 38
2024
Q4
$10.4M Buy
46,842
+70
+0.1% +$16K 0.37% 35
2024
Q3
$10.3M Buy
46,772
+1,968
+4% +$421K 0.39% 35
2024
Q2
$9.09M Sell
44,804
-1,678
-4% -$339K 0.37% 38
2024
Q1
$9.78M Sell
46,482
-623
-1% -$124K 0.4% 35
2023
Q4
$9.46M Sell
47,105
-565
-1% -$101K 0.43% 35
2023
Q3
$8.43M Sell
47,670
-1,495
-3% -$281K 0.43% 35
2023
Q2
$9.21M Sell
49,165
-247
-0.5% -$44K 0.47% 32
2023
Q1
$8.82M Sell
49,412
-3,501
-7% -$645K 0.46% 32
2022
Q4
$9.23M Buy
52,913
+364
+0.7% +$64.7K 0.47% 32
2022
Q3
$8.66M Sell
52,549
-1,990
-4% -$363K 0.42% 31
2022
Q2
$9.24M Buy
54,539
+289
+0.5% +$53.3K 0.45% 30
2022
Q1
$11.1M Sell
54,250
-1,224
-2% -$250K 0.61% 23
2021
Q4
$12.3M Buy
55,474
+2,351
+4% +$531K 0.66% 23
2021
Q3
$11.6M Sell
53,123
-2,471
-4% -$548K 0.68% 23
2021
Q2
$12.8M Buy
55,594
+4,796
+9% +$1.08M 0.72% 22
2021
Q1
$11.2M Buy
50,798
+377
+0.7% +$82.3K 0.72% 23
2020
Q4
$9.88M Sell
50,421
-4,828
-9% -$845K 0.67% 22
2020
Q3
$8.27M Buy
55,249
+149
+0.3% +$22.4K 0.65% 23
2020
Q2
$7.89M Sell
55,100
-23,886
-30% -$3.13M 0.73% 24
2020
Q1
$9.05M Buy
78,986
+2,281
+3% +$340K 0.89% 22
2019
Q4
$12.7M Sell
76,705
-41,400
-35% -$6.54M 1.18% 20
2019
Q3
$17.9M Sell
118,105
-689
-0.6% -$105K 1.6% 17
2019
Q2
$18.5M Sell
118,794
-3,895
-3% -$600K 1.54% 15
2019
Q1
$18.8M Buy
122,689
+9,408
+8% +$1.41M 1.53% 16
2018
Q4
$15.2M Sell
113,281
-230
-0.2% -$34.3K 1.15% 23
2018
Q3
$19.1M Sell
113,511
-11,444
-9% -$1.93M 1.64% 15
2018
Q2
$20.5M Sell
124,955
-8,414
-6% -$1.35M 1.75% 14
2018
Q1
$20.2M Buy
133,369
+105,151
+373% +$16.2M 1.77% 17
2017
Q4
$4.3M Sell
28,218
-140,268
-83% -$21.1M 1.26% 19
2017
Q3
$25M Buy
168,486
+82,054
+95% +$11.5M 2.09% 13
2017
Q2
$12.2M Sell
86,432
-48,464
-36% -$6.71M 1.06% 23
2017
Q1
$9.27M Buy
134,896
+37,942
+39% +$5.18M 0.79% 31
2016
Q4
$2.86M Buy
96,954
+88,793
+1,088% +$11.3M 0.26% 56
2016
Q3
$1.01M Sell
8,161
-174
-2% -$21.1K 0.1% 106
2016
Q2
$958K Sell
8,335
-11,653
-58% -$1.31M 0.09% 107
2016
Q1
$2.21M Buy
19,988
+10,930
+121% +$1.13M 0.21% 68
2015
Q4
$1.02M Sell
9,058
-134
-1% -$15.5K 0.11% 44
2015
Q3
$1M Sell
9,192
-498
-5% -$59K 0.08% 55
2015
Q2
$1.21M Buy
9,690
+22
+0.2% +$2.75K 0.12% 42
2015
Q1
$1.2M Sell
9,668
-778
-7% -$93.8K 0.16% 35
2014
Q4
$1.25M Sell
10,446
-6,628
-39% -$758K 0.17% 33
2014
Q3
$1.87M Sell
17,074
-2,096
-11% -$240K 0.26% 24
2014
Q2
$2.28M Sell
19,170
-1,104
-5% -$125K 0.31% 24
2014
Q1
$2.36M Sell
20,274
-263
-1% -$30.3K 0.34% 24
2013
Q4
$2.37M Buy
20,537
+12,157
+145% +$1.34M 0.37% 23
2013
Q3
$893K Sell
8,380
-6,694
-44% -$693K 0.16% 26
2013
Q2
$1.46M Buy
+15,074
New +$1.44M 0.23% 26

Other funds holding IWM

Aspiriant LLC's IWM Position: Q2 2026 in Review

Aspiriant LLC reduced its iShares Russell 2000 ETF (IWM) stake by 1.5% in Q2 2026, selling an estimated $233K and leaving 54,901 shares worth $16.5M. The position accounts for 0.41% of the portfolio, ranked #36.

Aspiriant LLC first reported a position in IWM in Q2 2013 and has held it in 53 quarters since. The position peaked at $25M in Q3 2017. 2,724 funds tracked by Wall St. Rank hold IWM as of Q2 2026.

  • Aspiriant LLC held 54,901 shares of iShares Russell 2000 ETF worth $16.5M as of Q2 2026.
  • Aspiriant LLC sold 829 iShares Russell 2000 ETF shares in Q2 2026, an estimated $233K.
  • iShares Russell 2000 ETF made up 0.41% of Aspiriant LLC's portfolio in Q2 2026, its #36 holding.
  • Aspiriant LLC first reported a position in iShares Russell 2000 ETF in Q2 2013 and has held it in 53 quarters since.
  • Aspiriant LLC's iShares Russell 2000 ETF position peaked at $25M in Q3 2017.
  • 2,724 funds tracked by Wall St. Rank held iShares Russell 2000 ETF as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.